Breaking News Instant updates and real-time market news.

ARGX

Argenx

$147.31

-2.56 (-1.71%)

, JNJ

Johnson & Johnson

$140.36

0.79 (0.57%)

18:03
12/08/19
12/08
18:03
12/08/19
18:03

Argenx data on cusatuzumab 'continues to impress,' says Piper Jaffray

Piper Jaffray analyst Edward Tenthoff said Argenx (ARGX) "continues to impress" with the Phase I data on cusatuzumab in combination with azacitidine in newly diagnosed AML patients presented at the ASH meeting this weekend. Argenx has received the first $25M milestone of up to $1.3B it is eligible for under Janssen (JNJ) licensing agreement, noted Tenthoff, who added that argenx retains a 50/50 U.S. profit share on the drug. He reiterated his Overweight rating and $177 price target on Argenx shares following the medical meeting.

ARGX

Argenx

$147.31

-2.56 (-1.71%)

JNJ

Johnson & Johnson

$140.36

0.79 (0.57%)

  • 08

    Dec

  • 09

    Dec

  • 16

    Dec

  • 22

    Jan

ARGX Argenx
$147.31

-2.56 (-1.71%)

10/22/19
JPMS
10/22/19
INITIATION
Target $167
JPMS
Overweight
Argenx initiated with an Overweight at JPMorgan
JPMorgan initiated coverage of Argenx with an Overweight rating and $167 price target.
11/05/19
FBCO
11/05/19
INITIATION
Target $137
FBCO
Neutral
Argenx initiated with a Neutral at Credit Suisse
Credit Suisse analyst Tiago Fauth initiated coverage of Argenx with a Neutral rating and $137 price target. In a research note to investors, Fauth says Argenx's strong performance over the past two years reflects heightened expectations, and while he believes Argenx has promising assets and solid fundamentals, he estimates current valuation already reflects substantial credit for its lead assets efgartigimod and cusatuzumab.
11/08/19
PIPR
11/08/19
NO CHANGE
Target $177
PIPR
Overweight
Argenx price target lowered to $177 from $182 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target on Argenx to $177 after its Q3 results and to reflect the deal dilution following its $657M equity raise. The analyst also keeps his Overweight rating on the stock, saying the company is on track to report Phase 2 efgartigimod in pemphigus vulgaris in the first half of 2020, along with its ongoing Phase I study of "ENHANZE subcu efgartigimod" with data expected by the end of this year.
11/18/19
RHCO
11/18/19
NO CHANGE
Target $160
RHCO
Buy
Argenx price target raised to $160 from $150 at SunTrust
SunTrust analyst Joon Lee raised his price target on Argenx to $160 and kept his Buy rating, saying its ENHANZE SC formulation data expected in the current quarter should offer "improved visibility" into the company's "competitive dynamic". The analyst notes that Intravenous Immunoglobulin, or IVIG, therapy used to treat auto-antibody mediated diseases is a "growing" $10B business and believes that Argenx's efgartigimod will be a major player in its emerging FcRn space, taking a "meaningful share" while possibly also leading expansion in that market.
JNJ Johnson & Johnson
$140.36

0.79 (0.57%)

11/19/19
CANT
11/19/19
INITIATION
Target $160
CANT
Overweight
Johnson & Johnson initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen initiated coverage of Johnson & Johnson with an Overweight rating and $160 price target.
11/20/19
CANT
11/20/19
INITIATION
Target $160
CANT
Overweight
Cantor Fitzgerald starts Johnson & Johnson with Overweight, $160 price target
Cantor Fitzgerald analyst Louise Chen last night initiated coverage of Johnson & Johnson with an Overweight rating and $160 price target. Upwards earnings revisions to J&J's Pharma business and multiple expansion, driven by diminishing headlines risks from talc and opioids, should move the shares higher, Chen tells investors in a research note. She points out that Johnson & Johnson has reported eight consecutive years of pharma operational sales growth of 8.9% annually, about twice as fast as the global market. The analyst also thinks the company's liabilities from talc and opioids are manageable with its cash balance, as well as its cash flow from operations.
11/20/19
11/20/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) initiated with an Overweight at Cantor Fitzgerald. 2. Brink's (BCO) initiated with a Buy at Goldman Sachs. 3. KLA-Tencor (KLAC) initiated with a Buy at Nomura Instinet. 4. NexTier Oilfield (NEX) initiated with a Buy at Citi. 5. Carrols Restaurant (TAST) initiated with a Buy at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/08/19
PIPR
12/08/19
NO CHANGE
PIPR
Piper says Bluebird's bb2121 'clearly approvable,' but competition heating up
Piper Jaffray analyst Tyler Van Buren said the topline results presented by Bluebird Bio (BLUE) at ASH from the KarMMa trial are "impressive in these very sick patients" and he believes that the drug is "clearly approvable." However, he also said that the JNJ-4528 Legend data presented by Johnson & Johnson's (JNJ) Janssen "appears very competitive," adding that "we would be remiss if we didn't mention the continued deluge of anti-BCMA antibody data" from competitors including Amgen (AMGN), Bristol-Myers (BMY) and Regeneron (REGN). Van Buren keeps a Neutral rating on Bluebird Bio shares, citing valuation as well as his view on long-term competitive pressures.

TODAY'S FREE FLY STORIES

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

, PUGOY

Peugeot

$0.00

(0.00%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Periodicals
Fiat Chrysler CEO says PSA deal talks 'progressing really well,' Reuters says »

Fiat Chrysler (FCAU) CEO…

FCAU

Fiat Chrysler

$13.51

-0.135 (-0.99%)

PUGOY

Peugeot

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.66

0.345 (6.49%)

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
01/22/20
01/22
12:25
01/22/20
12:25
Conference/Events
The Executives' Club of Chicago to hold a luncheon meeting »

The Executives' Club…

SRPT

Sarepta

$121.03

-1.65 (-1.34%)

12:24
01/22/20
01/22
12:24
01/22/20
12:24
Periodicals
New documents point to 'deeper' FDA concerns about Sarepta's Vyondys, STAT says »

New documents released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$1.96

0.04 (2.08%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Hot Stocks
Proteostasis to present data from organoid study in CF treatment »

Proteostasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/22/20
01/22
12:17
01/22/20
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNA

Moderna

$21.97

1 (4.77%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Recommendations
Moderna analyst commentary  »

Moderna mRNA technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/22/20
01/22
12:16
01/22/20
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
01/22/20
01/22
12:15
01/22/20
12:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude hit…

TWLO

Twilio

$119.62

0.47 (0.39%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
Periodicals
Breaking Periodicals news story on Twilio »

Hedgeye adds Twilio to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 24

    Feb

NFLX

Netflix

$332.00

-6.24 (-1.84%)

, IBM

IBM

$143.22

4.07 (2.92%)

12:12
01/22/20
01/22
12:12
01/22/20
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rebounding…

NFLX

Netflix

$332.00

-6.24 (-1.84%)

IBM

IBM

$143.22

4.07 (2.92%)

AAPL

Apple

$318.43

2.04 (0.64%)

ETN

Eaton

$97.23

2.72 (2.88%)

ABT

Abbott

$92.33

2.57 (2.86%)

NAVI

Navient

$15.02

1.16 (8.37%)

ARNC

Arconic

$28.60

-0.795 (-2.71%)

FCEL

FuelCell

$2.14

-0.735 (-25.61%)

NTRS

Northern Trust

$102.32

-6.35 (-5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 27

    Jan

  • 28

    Jan

  • 04

    Feb

NTDOY

Nintendo

$0.00

(0.00%)

12:09
01/22/20
01/22
12:09
01/22/20
12:09
Periodicals
Judge says iLife's patent suit against Nintendo not valid, Verge says »

Federal Judge Barbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WILC

G. Willi-Food

$12.22

-0.21 (-1.69%)

12:06
01/22/20
01/22
12:06
01/22/20
12:06
Hot Stocks
G. Willi-Food CEO Michael Luboschitz to resign for personal reasons »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.41

0.77 (2.51%)

12:05
01/22/20
01/22
12:05
01/22/20
12:05
Options
Elanco Animal Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 23

    Jan

HUYA

Huya

$18.73

-1.75 (-8.54%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Huya falls -8.5% »

Huya is down -8.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMRE

Costamare

$9.01

-1.34 (-12.95%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Costamare falls -12.9% »

Costamare is down -12.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANG

Cango

$7.28

-0.71 (-8.89%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Cango falls -9.3% »

Cango is down -9.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCFT

OneConnect

$15.17

1.2 (8.59%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
OneConnect rises 8.5% »

OneConnect is up 8.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Periodicals
Bombardier subway cars returning to service this week in NYC, Reuters says »

Bombardier subway cars…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

FSB

Franklin Financial Network

$38.25

4.13 (12.10%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Franklin Financial Network rises 12.6% »

Franklin Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$4.88

0.73 (17.59%)

12:00
01/22/20
01/22
12:00
01/22/20
12:00
Hot Stocks
Express rises 17.5% »

Express is up 17.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

BTI

British American Tobacco

$44.63

0.06 (0.13%)

11:56
01/22/20
01/22
11:56
01/22/20
11:56
Upgrade
British American Tobacco rating change  »

British American Tobacco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPR

Spirit AeroSystems

$64.32

-0.24 (-0.37%)

11:55
01/22/20
01/22
11:55
01/22/20
11:55
Options
Spirit AeroSystems put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HARL

Harleysville Savings Financial Corp

$0.00

(0.00%)

11:53
01/22/20
01/22
11:53
01/22/20
11:53
Earnings
Harleysville reports Q1 EPS 50c vs. 57c last year »

Q1 net income included a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

HARL

Harleysville Savings Financial Corp

$0.00

(0.00%)

11:51
01/22/20
01/22
11:51
01/22/20
11:51
Hot Stocks
Harleysville increases quarterly cash dividend 8% »

Harleysville Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.